Sinistral or left-sided portal hypertension is a localized form of portal hypertension usually due to isolated obstruction of splenic vein. Most commonly, it is secondary to pancreatitis. Rarely this can present as life-threatening gastric variceal bleeding. In such patients, splenectomy is traditionally considered as the treatment of choice to relieve venous hypertension. Unfortunately, a surgical operation may not be safe in most of the patients because of the unfavorable operative field. Splenic artery embolization (SAE) is an effective method, theoretically akin to splenectomy, blocking the direct arterial inflow to the spleen and thereby reducing the outflow venous pressure. The authors demonstrate a case of a 58-year-old man who presented with severe gastric variceal hemorrhage due to sinistral portal hypertension (SPH) secondary to an episode of pancreatitis, which he had 1 month back. He was successfully managed by SAE and remains symptom-free. The authors bring to the fore the potential curability of gastric variceal hemorrhage secondary to SPH using SAE, which is a safe and effective interventional radiologic procedure.
Introduction
Sinistral portal hypertension (SPH) is a rare entity with an incidence of <1%. 1 It is characterized by localized portal hypertension, most commonly due to thrombosis of splenic vein resulting in venous hypertension. This may lead to gastric variceal formation, which eventually may cause life-threatening hematemesis. SPH is also known as left-sided, regional, segmental, isolated, or splenoportal hypertension. Such a condition is traditionally treated by splenectomy aiming at the reduction of gastric variceal pressure building up from the splenic side. Splenic artery embolization (SAE) is a proven endovascular treatment for various disease processes and is emerging as a surgical substitute where it is clinically appropriate. Its role in SPH is not well known and is always placed down among the list of indications for SAE.
We attempt to review the role of SAE as a curative treatment for gastric variceal hemorrhage secondary to SPH along with the demonstration of a case of SPH presented to our hospital with life-threatening gastric variceal bleeding, which was successfully managed by SAE highlighting the shifting trend of management options from surgical to interventional radiology technique.
Splenic Arterial Anatomy
As endovascular physicians, the fact which we need to keep in mind is that the splenic artery not only supplies the spleen, but also the parts of the pancreas (arteria pancreatica magna and the dorsal pancreatic artery) and stomach (short gastric, posterior gastric, and left gastroepiploic arteries). 2 These arteries need to be demonstrated by angiogram especially the greater pancreatic artery to avoid unintentional embolization and complications. Hence, embolization should be done distal to the origin of pancreatic branches. At the hilum, splenic artery divides into superior and inferior terminal branches, which further divides into multiple segmental intrasplenic arteries. Majority of the spleen is supplied by the superior terminal branch.
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Pathophysiology of SPH
Sinistral portal hypertension is a clinical syndrome characterized by segmental portal venous hypertension and its sequelae, usually secondary to splenic vein thrombosis (SVT). 3 Most of the time, etiology for SVT is pancreatitis because of its closer anatomic relation (►Fig. 1A). 4 Since splenic vein runs along the posterior aspect of the pancreas, any pathology of the pancreas can affect the splenic vein. 5 Sometimes SPH is associated with unexplained splenomegaly, which is often greater than that of due to portal hypertension if the patient has concomitant liver cirrhosis. 6 The incidence of SPH is increasing probably due to better diagnosis. Most of the patients with SPH remain asymptomatic making the exact estimation of its incidence difficult, but it is generally considered as <5% in patients with portal hypertension. 7 Development of SPH is not related to the severity of pancreatitis. Single episode of acute pancreatitis can also lead to SVT and present later as gastric variceal hemorrhage secondary to SPH. It can remain asymptomatic in SVT secondary to chronic pancreatitis also. 8 Pathophysiology of SPH is straightforward (►Fig. 1B). Venous hypertension secondary to splenic vein obstruction is the root cause. 3 Obstruction of splenic vein results in increased pressure in collaterals that divert blood to superior mesenteric and portal venous systems. This includes the short gastric, gastroepiploic, coronary veins, and the veins located in the fundus of the stomach. The characteristic feature is the formation of exclusive fundal gastric varices without the presence of esophageal varix. This is because the redirected splenic venous blood into the gastric fundal veins via short gastric vessels will eventually decompress via the coronary and epiploic veins into portal system, typically into the main portal vein (►Fig. 2A). Hence, backpressure is not transmitted to esophageal submucosal veins. 9 Due to various anatomic variations in the drainage of coronary and epiploic veins, SPH can present sometimes with esophageal varices also and need not always result in portal hypertension and any varix formation at all. 10
Diagnosis
Most of the patients with SPH remain asymptomatic. Chronic abdominal pain and upper gastrointestinal (GI) bleeding are the most common complaints. 9 Diagnosis is most commonly incidental to routine evaluation or in an acute setting where the patient presents with upper GI hemorrhage. Diagnosis is mainly clinical by excluding systemic portal hypertension while imaging plays an important role in ruling out other causes. Most of the time it is difficult to differentiate the cause of variceal hemorrhage from general portal hypertension secondary to hepatic cirrhosis. 10 It is important to differentiate the etiology because the management is different in varices secondary to general portal hypertension and in SPH. The initial diagnostic procedure is upper GI endoscopy, which shows characteristic fundal gastric varices with sparing of rest of the stomach and esophagus. The endoscopic appearance of varices ranges from evident dilated submucosal veins to multiple thin linear nodularities in the fundal gastric mucosa. 11 Transabdominal ultrasonography (US) helps in detecting SVT and portal vein thrombosis, but is highly dependent on the anatomic location of the thrombus and its extent of involvement. US is more useful as a diagnostic tool to exclude systemic portal hypertension by excluding hepatic cirrhosis. 3 Endoscopic ultrasonography (EUS) is more useful than US is in evaluating splenic vein. 12 It is more useful than US in evaluating the pancreatic parenchyma and to detect any mass lesions or any small focus of pancreatitis. 13 EUS is reported to be more sensitive than conventional endoscopy in detecting gastric varices. 14 Contrast-enhanced computed tomography (CECT) in portographic phase is useful in detecting SVT. It can also demonstrate isolated fundal gastric varices. Pancreatic pathology varying from focal pancreatitis, necrotizing pancreatitis to chronic pancreatitis, can also be seen in this modality. 15 Digital subtraction angiography (DSA) remains the gold standard diagnostic modality for detecting SVT. 16 Nonopacification of splenic vein in venous phase of splenic artery injection confirms SVT. It accurately detects the location and extent of thrombosis. Most of the time splenic hilar venous collaterals and opacification of dilated short gastric and gastroepiploic veins are also seen. 17 All the above-mentioned diagnostic modalities can miss SVT, especially thrombosis of proximal splenic vein which can only be evident intraoperatively. 18 
Management
Sinistral portal hypertension is one of the curable and rarest syndromes of portal hypertension. 19 Most commonly patients with SPH present with acute variceal hemorrhage. 20 This may arise from gastric, esophageal, or sometimes even from colonic varices and can be life threatening. 21 After the initial bleeding control measures to stabilize the patient, treatment is aimed at the reduction in portal hypertension from the splenic side because the rest of the portal system is normal. Medical management including vasoconstrictive agents and endoscopic procedures, such as balloon tamponade and sclerotherapy, are useful only as initial conservative attempts to control bleeding. Most often these methods turn out futile. 3, 20 Unlike in systemic portal hypertension, refractory variceal hemorrhage cannot be controlled by endoscopic banding or proximal portal decompressive procedures, such as portosystemic shunts, which may be even hazardous. 22 Management of SPH has seen the evolution of its treatment strategy from surgical to endovascular techniques. Earlier, splenectomy was the preferred treatment for SPH. 23 It was based on the fact that it can cut down the arterial supply to the collateral draining veins and gastric fundal varices and thereby results in the reduction of venous hypertension and risk of bleeding 7 (►Fig. 2B). However, splenectomy may not be a safe option for patients who are in an unstable condition due to massive blood loss. Also, the inflammatory process, most commonly like that of pancreatitis, makes the operative field unfavorable. 24 Splenectomy is also associated with immunological and hematological complications. 25 This was negotiated by the introduction of 'Warshaw operation,' which is a spleenpreserving operation originally developed for distal pancreatectomy. Segmental resection of splenic vessels result in decreased blood pressure in the spleen and thereby reducing venous hypertension and subsequent resolution of gastric varices. Sufficient blood supply for the survival of spleen and its immunologic functioning will be taken care by short gastric and gastroepiploic vessels 26 (►Fig. 2C).
Based on the same principle, SAE can be used as an " endovascular Warshaw operation." Here, embolized splenic artery and the already pathologically thrombosed splenic vein create a similar setting of reduced splenic blood load and resultant variceal decompression similar to Warshaw operation (►Fig. 2D). SAE in a case of SPH was described as " nonsurgical splenectomy" by Jones and de Koos citing similar reasons. 27 A major concern, as in our case, against performing SAE in SPH is about splenic abscess formation and complete infarction of spleen. 22, 27 This will jeopardize the intention of preserving the immunohematological function of the spleen. Partial SAE can overcome this disadvantage to an extent and can also reduce complications such as post-embolization syndrome. 10 There is no published data about immunologic consequences after SAE and the role of vaccination prior to non-surgical splenic interventions. 28 However; some authors are of the opinion that partial SAE is associated with more complications compared with total SAE, especially if the volume of infarction is more than 50%. 29 As a general rule, complete splenic embolization is not performed due to the possibility of developing severe complications. 30 Partial SAE can be done in two methods-selective and nonselective. In selective embolization, few distal branches are selectively cannulated and completely embolized, and other vessels are left unembolized. Splenic angiogram in the parenchymal phase subsequently can assess the amount of spleen embolized, and more branches can be selected and embolized if needed. In the non-selective method, the main trunk of the splenic artery is embolized just distal to the origin of pancreatic branches, and the particles are injected until there is a reduction in parenchymal blush. Non-selective embolization is considered superior to selective embolization in SPH. This is because of the reduced amount of splenic infarct and subsequent complications meantime attaining desired preservation of splenic function. 31, 32 
How We Do It
Our patient was a 58-year-old man who presented with severe hematemesis about 1 month after he had an episode of necrotizing pancreatitis (►Fig. 3A, B) , which was conservatively managed. His hemoglobin (Hb) level was 6.8 g/dL. He was transfused with two pints of packed red blood cells and was on inotropic support. After stabilizing the patient, a CECT of the abdomen was done, which showed walled-off pancreatic necrosis with SVT (►Fig. 3C) and prominent gastric varices (►Fig. 3D). There was splenomegaly. No cirrhotic features were noted. Gastroscopy showed multiple thin varices predominantly in the fundus (►Fig. 4A), which was not amenable for any endoscopic obliterative procedures. Meantime patient became clinically better with Hb level of 8.1 g/dL. Splenectomy was the initial consideration. However, the surgical team refused to intervene citing unfavorable operative field due to severe inflammation and adhesions secondary to pancreatitis.
Splenic artery embolization was offered on interventional radiology (IR) consultation. The decision for SAE was taken after a multidisciplinary team discussion. Main concern during the discussion especially by the surgical team was about the formation of a splenic abscess. This was reassured by the IR team giving the option of pigtail drainage if needed, in case of an abscess formation. Meanwhile the patient had one more episode massive hematemesis (approximately 500 mL), and Hb dropped to 6.6 g/dL. He was taken up for emergency SAE.
Technique
Splenic artery access was made via the right femoral artery route using standard angiographic techniques. A 5F cobra catheter (Cook Medical) was used for selective cannulation of the celiac artery. Celiac angiogram (►Fig. 5A) showed normal splenic artery, which was super selectively cannulated using a microcatheter (Progreat, Terumo Corporation) (►Fig. 5B). Non-selective particle embolization of the splenic artery was done using 300 to 500 µm polyvinyl alcohol (PVA) particles (Embosphere Microspheres, Merit Medical System) until there was sufficient stasis of blood flow (►Fig. 5C). Further coil embolization was done using three micro coils-two 8 mm × 7 cm and one 2 mm × 7 cm coils (Nester, Cook Medical). Check angiogram showed absent forward flow (►Fig. 5D). Pancreatic branches were not visualized, and unintentional embolization of these branches was not of concern in this case since the patient already had pancreatic necrosis. He was observed in the intensive care unit for a day and was shifted to ward. Gastroscopy on the third day of embolization showed significant reduction in gastric fundal varices (►Fig. 4B). The patient did not develop any post-embolization complications. He was discharged from the hospital on the fourth day of SAE. Follow-up CECT of the abdomen after a month showed complete resolution of gastric fundal varices with near total infarction of the spleen (►Fig. 6A). Coils in the splenic artery were also demonstrated (►Fig. 6B). There was avascular spleen with altered echotexture with no splenic abscess formation, and the patient was asymptomatic at 4 months follow-up. At 6 months, our patient remained asymptomatic. There was a cystic replacement of entire splenic parenchyma with a small amount of residual tissue in the region of upper pole. Roughly, ~85% infarction of spleen was noted.
Discussion
The indications for SAE (►Table 1) involves various specialties. Hence, most of the SAEs are done based on multidisciplinary consensus. There are no absolute contraindications for SAE. Relative contraindications are uncorrectable coagulopathy, severe renal insufficiency, acute or chronic infection of spleen, pregnancy, planned radioiodine therapy for thyroid carcinoma, and contraindications to angiography such as a severe anaphylactoid reaction to iodinated contrast. 33 
Embolization Methods
Partial splenic artery embolization (PSE) is the standard embolization method. This was developed by Spigos et al in 1979. 34 The most important advantage of PSE, especially over splenectomy is that it maintains the splenic function. This can be done as (i) selective or (ii) non-selective, as described above. In SPH, non-selective SAE appears to be better than selective SAE. Usually, non-selective SAE causes only ~20 to 30% of splenic infarct, which is sufficient to reduce the intrasplenic arterial blood pressure and to achieve resolution of bleeding varices in SPH. 31 We used coils to block the major vessel proximally to achieve a reduction in overall splenic inflow pressure, 35 which is the primary intention in any case of SPH. The secondary intention was to reduce the possibility of splenic rupture following embolization, especially because the patient had splenomegaly. 36 However, coil embolization, which is the preferred method of SAE in trauma, has a disadvantage in this scenario. Spleen gets collateral supply from short gastric and gastroepiploic arteries, which allows itself to repair without infarction. This is beneficial in case of trauma, 37 but it can result in recurrence of symptoms and failure of treatment in case of SPH. This was tackled by using PVA particles of 300 to 500 µm, which blocks the splenic blood supply at the parenchymal level so that even if collateralization happens the functional splenic parenchyma undergoes dry infarction. 38
Embolization Agents
Most commonly used embolization agents for SAE are coils, PVA, and gelatin pledgets. 39 Vascular plugs can also be used at the distal splenic artery just proximal to branching of hilar vessels. 40 Agents like absolute alcohol and lipiodol are cheaper and readily available alternatives. 28 Silk suture material (4-0 or 5-0) cut in 2-mm length have also been used as embolic agent. 38 Advantage of smaller particle agents like PVA and 2-mm silk suture bits is that it floats in the blood vessels and reaches downstream and block the vessels supplying the red pulp, which is the functional area of spleen. 41 Coil embolization is reported to have less post-embolization pain or other complication. However, there is high chance revascularization of spleen and recurrence of symptoms, especially in a case of hypersplenism. 41 Smaller particles like 300 to 500 µm PVA causes early and more severe post-embolization pain. Most likely, this is due to distal embolization and peripheral infarction resulting in exudates and subcapsular fluid accumulation and capsular stretching. However, PVA is effective as a permanent embolization agent because of lesser recurrence rate and decreased incidence of fever and infection compared with other agents.
Complications
Splenic artery embolization is associated with complications including puncture site-related ones like any other interventional procedures. The incidence of major complications is ~19% and of minor complications is ~23%. The most common major complication is inadequate embolization resulting in persistent hemorrhage. There is only a 3% chance of developing splenic abscess requiring drainage. Splenic rupture, coil migration, gastric wall necrosis, and pancreatitis are rarer complications. Postembolization syndrome (fever < 39°C, left upper quadrant pain, nausea, abdominal fullness, and loss of appetite) and reactive left pleural effusion are considered as side effects, not as complications. These symptoms usually last 3 to 10 days. 42 Postembolization syndrome may be as common as 30%, but usually resolve without any residual effects. 43 Complications can be minimized by meticulous technique and selective embolization. The severity of complications correlates with the amount of infarcted splenic tissue. 44 Majority of the serious complications occurred when the volume of embolization was more than 80%. Hence, the volume of the first embolization should be less than 70% to minimize the complications. 45 In our case, this may be considered as a drawback since we had an infarct of ~85%. However, our patient did not develop any complications. Distal embolization bypassing the splenic and gastric branches can avoid gastric wall necrosis and pancreatitis due to non-target embolization.
Presence of intrasplenic air, unlike in other organs does not always indicate abscess formation. It is reported that only 17% of cases with intrasplenic air were found to have an infection. This is 50% if there is a large amount of air. Usually, abscess formation is very rare and can be easily managed percutaneously or rarely by splenectomy. 46 In general, 'Spigos technique' (►Table 2) has been used to reduce the complications; however, different centers have their own modifications. 34
Follow-Up
There is no standard protocol for follow-up in SAE for the treatment of SPH. Continuous monitoring of vitals in an intensive care set up for at least a day post procedure if the patient is hemodynamically unstable. We do serial Hb monitoring and early post-procedure upper GI endoscopy (usually on the next day of embolization) to assess the hemodynamic status and the fundal varices, respectively. Immediate resolution of varices compared with pre-procedure endoscopy is usually seen. The patient can be discharged in 3 to 5 days if post-embolization symptoms are relieved. Doppler US examination of the spleen before discharge to look for intrasplenic vascularity and splenic echotexture is usually done. CECT may be done after a month to assess the amount of viable spleen and the fundal gastric varices. Thereafter, serial abdominal US examinations may be done to assess the portal system for any thrombosis and to assess the infarcted spleen if the patient is symptomatic.
In follow-up after SAE for hypersplenism, serial platelet count improvement is noted after a good volume of splenic infarct with a peak response at 3 days and at 1 month. 47 Platelet count monitoring along with Hb level may be used as an indirect indicator for successful embolization and for follow-up.
Vaccination
Routine vaccination in a case of splenectomy is recommended and is effective against overwhelming post-splenectomy infections (OPSI). 48 OPSI is common after surgical splenectomy as it leads to a state of asplenia. 49 However, there is no data supporting the routine use of vaccination for OPSI in patients undergoing non-surgical splenic interventions. Its use in non-surgical patients and in partial splenectomy has been reduced. 50 In a 26-month follow up study done by Bessoud et al in 24 patients who underwent proximal SAE, only two patients had Howell-Jolly bodies in the peripheral blood indicating inadequate splenic phagocytic function. All the patients had immunity against Haemophilus influenza. 51 To our knowledge, there is no published data on the immunological outcomes after splenic artery interventions or on the role of vaccination and its routine use in SAE. In our patient, since it was an emergency procedure, vaccination was not given. We feel it is not indicated on follow-up because of the functioning residual splenic tissue in the upper pole.
Conclusion
Splenic artery embolization is a minimally invasive endovascular procedure, which may be considered as a potentially safe and effective treatment for SPH. SAE avoids splenectomy and can effectively control the gastric fundal variceal bleeding and simultaneously preserve the immunohematological functions of the spleen. We demonstrate an example, which emphasizes the role of interventional radiology in the management and curative treatment of this rare but life-threatening entity. Further evaluation with a large number of cases and long-term follow-up is required to establish the role of SAE in SPH on a larger perspective. However, those physicians who are primarily dealing with SPH should be aware of the role of interventional radiology in the management of SPH and its advantages.
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